Creative Biolabs has announced a focused portfolio of research products and services aimed at supporting functional evaluation and experimental control in complement biology and droplet microfluidics. The offerings address common challenges such as assay variability, limited functional readouts, inconsistent droplet formation, and fragmented workflows that can complicate data interpretation and slow research progress. By providing tools that emphasize reliable measurements and well-defined experimental conditions, the company aims to help translational researchers generate more robust data.
In complement therapeutics, understanding whether a drug candidate modulates pathway activity at the functional level is critical. Binding data alone may not reveal downstream biological effects, making functional assays essential for inhibitor characterization. Creative Biolabs offers a CH50 functional test kit that measures classical pathway activity via antibody-sensitized red blood cell lysis. The kit supports serum or plasma samples from multiple species, including humans, mice, and rats, and is suitable for complement function studies and research on inhibitors or activators.
For more detailed functional profiling, the company provides a hemolysis inhibition profiling service that assesses changes in complement-mediated lysis following inhibitor treatment. By examining concentration-dependent inhibition, the service aids in potency assessment, comparative activity profiling, and mechanism-of-action investigations. Classical or alternative pathway assays can be incorporated to address pathway-specific questions, allowing researchers to distinguish target binding from functional inhibition under defined conditions.
In droplet microfluidics, researchers face the challenge of generating consistent droplets for encapsulation, screening, and compartmentalized assays. Creative Biolabs' flow focusing droplet generation chip uses a flow-focusing configuration to promote uniform droplet formation within microchannels. The PDMS-based chip is designed for water-in-oil and oil-in-water droplet generation and can be applied to single-cell encapsulation. Such systems may help establish more controlled experimental conditions and support the development of droplet-based screening workflows.
Although complement testing and droplet microfluidics address distinct experimental requirements, both highlight the importance of selecting appropriate research tools and measurable endpoints. By offering functional complement assay solutions alongside microfluidic research tools, Creative Biolabs aims to support researchers in refining workflows, broadening functional characterization, and choosing formats suited to different biological questions. All referenced products and services are intended for research use only and are not for diagnostic or therapeutic use in humans. Researchers can explore the complement portfolio at https://www.creative-biolabs.com/complement-therapeutics/.
